| abstract |
REFERS TO A FORM OF HORMONE ADMINISTRATION THAT CONSISTS OF A PLURALITY OF PACKAGING UNITS THAT INCLUDE A CONSTANT INTAKE PERIOD (22 DAYS) OF A HORMONE COMPONENT SUCH AS 0.5mg TO 3mg OF CHLORMADINONE ACETATE, 1mg TO 3mg OF CYPROTERONE ACETATE; 0.05mg TO 0.2mg OF DESOGESTREL, 1mg TO 3mg OF DIENOGEST, 0.035 TO 0.1mg OF LEVONOGESTREL; 0.25mg TO 3mg OF LINESTRENOL, AMONG OTHERS THAT ACT AS A CONTRACEPTIVE; PAUSE PERIOD OF 4 TO 10 DAYS CONSISTS OF THE INTAKE OF A PLACEBO FREE OF ALL HORMONE COMPONENTS OR SAID PERIOD IS FREE OF ALL ADMINISTRATION; THE METHOD IS CHARACTERIZED BECAUSE THE DURATION OF THE INTAKE PHASE OF THE PERIOD PRECEDING THE NEXT INTAKE PERIOD IS LESS THAN EACH OF THE FOLLOWING PERIODS, THE FINAL INTAKE PERIOD BEGINS LATER THAN THE ELEVENTH |